Martine A. Rothblatt
CIK: 0001106578
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (2,402 total)
- Nov 2, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect1.3K shares at avg. $597.95$765K - Nov 2, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect223 shares at avg. $593.09$132K - Nov 2, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect905 shares at avg. $594.03$538K - Nov 2, 2026UTHR
UNITED THERAPEUTICS Corp
Exercise(M)Indirect9.5K shares at avg. $117.76$1.1M - Nov 2, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect200 shares at avg. $598.84$120K - Nov 2, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect2.8K shares at avg. $596.11$1.7M - Nov 2, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect2.5K shares at avg. $597.02$1.5M - Nov 2, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect1.6K shares at avg. $595.15$952K - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect80 shares at avg. $606.91$49K - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect1.2K shares at avg. $600.25$720K - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect40 shares at avg. $608.05$24K - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect577 shares at avg. $603.13$348K - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect884 shares at avg. $598.94$529K - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect1.5K shares at avg. $598.04$895K - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect728 shares at avg. $596.01$434K - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect183 shares at avg. $603.89$111K - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect40 shares at avg. $605.33$24K - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect393 shares at avg. $596.84$235K - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect119 shares at avg. $594.92$71K - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Exercise(M)Indirect9.5K shares at avg. $117.76$1.1M - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect1.7K shares at avg. $600.96$1.0M - Oct 30, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect2K shares at avg. $601.94$1.2M - Oct 29, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect1.6K shares at avg. $592.97$927K - Oct 29, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect53 shares at avg. $590.43$31K - Oct 29, 2026UTHR
UNITED THERAPEUTICS Corp
Sale(S)Indirect1.5K shares at avg. $593.88$915K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 2, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 1,280 | $597.95 | $765,371 | Indirect |
| Nov 2, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 223 | $593.09 | $132,259 | Indirect |
| Nov 2, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 905 | $594.03 | $537,597 | Indirect |
| Nov 2, 2026 | UTHR UNITED THERAPEUTICS Corp | Exercise(M) | 9,500 | $117.76 | $1,118,720 | Indirect |
| Nov 2, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 200 | $598.84 | $119,768 | Indirect |
| Nov 2, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 2,776 | $596.11 | $1,654,807 | Indirect |
| Nov 2, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 2,517 | $597.02 | $1,502,690 | Indirect |
| Nov 2, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 1,599 | $595.15 | $951,644 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 80 | $606.91 | $48,553 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 1,200 | $600.25 | $720,302 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 40 | $608.05 | $24,322 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 577 | $603.13 | $348,008 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 884 | $598.94 | $529,465 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 1,496 | $598.04 | $894,664 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 728 | $596.01 | $433,893 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 183 | $603.89 | $110,512 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 40 | $605.33 | $24,213 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 393 | $596.84 | $234,557 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 119 | $594.92 | $70,795 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Exercise(M) | 9,500 | $117.76 | $1,118,720 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 1,742 | $600.96 | $1,046,865 | Indirect |
| Oct 30, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 2,018 | $601.94 | $1,214,707 | Indirect |
| Oct 29, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 1,563 | $592.97 | $926,810 | Indirect |
| Oct 29, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 53 | $590.43 | $31,293 | Indirect |
| Oct 29, 2026 | UTHR UNITED THERAPEUTICS Corp | Sale(S) | 1,540 | $593.88 | $914,574 | Indirect |
1-25 of 2,402 transactions
About ROTHBLATT MARTINE A
ROTHBLATT MARTINE A (SEC CIK 0001106578) files insider reports with the SEC as Chairperson & CEO of UNITED THERAPEUTICS Corp (UTHR) and Director of BETA Technologies, Inc. (BETA).
Signal8 holds 214 ownership filings by ROTHBLATT MARTINE A (1 Form 3, 213 Form 4), filed between Mar 11, 2025 and Nov 3, 2026. Those filings report 2,402 transactions, from Mar 15, 2023 to Nov 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ROTHBLATT MARTINE A's filings is in SILVER SPRING, MD.
Recent filings by ROTHBLATT MARTINE A
- Nov 2, 2026: Open-market sales of UTHR shares (3 lines, Form 4, code S).
- Nov 2, 2026: Option exercise of UTHR shares (Form 4, code M).
- Nov 2, 2026: Open-market sales of UTHR shares (4 lines, Form 4, code S).
- Oct 30, 2026: Open-market sales of UTHR shares (11 lines, Form 4, code S).
- Oct 30, 2026: Option exercise of UTHR shares (Form 4, code M).
Other insiders filing for UNITED THERAPEUTICS Corp (UTHR)
- MAHON PAUL A, EVP & GENERAL COUNSEL
- Mesa Nilda, Director
- DZAU VICTOR J, Director
- MAXWELL LINDA, Director
- Thompson Tommy G, Director
- Tracey Kevin, Director